ENDO is Here!
ENDO 2019 has come to New Orleans this week, but it is not too late to register! We offer 1- and 2-day registration packages, offering you the flexibility to customize your schedule. We look forward to seeing you!
There are many ways to get from the airport to your hotel and around New Orleans. Check out our transportation guide on how to get around.
Save the date for our upcoming 2019 meetings! Endocrine Board Review (EBR) 2019 and Clinical Endocrinology Update (CEU) are coming to Seattle, Washington, Sept. 17–21. CEU will also be in Miami, Florida, Sept. 5–7. See you there!
Upcoming Diabetes CPG
Check out the "Treatment of Diabetes in Older Adults" session at ENDO 2019 to coincide with the launch of the guideline on March 23, in New Orleans, LA.
Visit endodaily.org to find coverage of ENDO 2019 sessions and meeting news.
- ENDO 2019 Preview: Constant Craving: Linking Addiction and Endocrinology—A variety of cases will be presented at ENDO 2019 that will demonstrate how certain endocrine treatments can cause or worsen addictive behaviors
- Meet your 2019 Laureates
- ENDO 2019 Preview: Transgender Basics and Beyond
- ENDO 2019 Preview: Tailored Programming for Early-Career Members
- Aging Gracefully: Targeting Cellular Senescence in Age-Related Osteoporosis and Frailty
- Way Down Yonder: A New Orleans Travel Guide
Special ENDO 2019 Receptions
ENDO has an abundance of educational opportunities, and we invite you to relax at the end of each day at our receptions. These are excellent opportunities to unwind and network with colleagues and renowned experts in the field. Refreshments are provided.
Lilly Diabetes Educational Exchange
Saturday, March 23, from 5:30 until 7:15 PM, come to this educational evening in which you will learn the latest advances in diabetes care. Space is limited, so be sure to RSVP!
Basic Science Pathway Receptions
This year's Basic Science Pathways will all conclude with a reception.
- Reproductive Endocrinology: Saturday, March 23: 5:45-7:00 PM
- Nuclear Receptors and Gene Regulation: Sunday, March 24: 5:30-7:00 PM
- Neuroendocrinology: Monday, March 25: 5:45-7:00 PM
Committee on Diversity and Inclusion Receptions
- LGBTQ and Allies Reception–Saturday, March 23, 2019, 5:30 PM - 6:30 PM
- Mentoring and Poster Reception–Sunday, March 24, from 7:00 until 9:30 PM
- March 24 - 27, 2019 | Keystone Symposia on Origins of Allergic Disease | Lake Tahoe, California, United States
- March 26 - 29, 2019 | 16th International Workshop on Multiple Endocrine Neoplasia | Houston, Texas, United States
- April 4 - 6, 2019 | Thyroid Fest | Mazatlan, Sinaloa, Mexico
The ENDO 2019 Mobile App is available for download from the:
And please visit the ENDO 2019 App page for highlights and instructions.
Visit endodaily.org to find coverage of ENDO 2019 sessions and meeting news. Find out what you missed, get the highlights from a variety of sessions, or check out session previews and interviews with ENDO movers and shakers.
Our Continuing Medical Education Services (CMES) offer even more opportunities to hear from experts with Conference Events. There is no cost for these events, and admission will be done on a first-come, first-served basis. Sessions include:
- Patient-Centered Approaches to Long-Term Success in Weight Loss
- New Medical Options for the Treatment of Advanced Thyroid Cancer
- Unraveling the Genetics of Rare Causes of Obesity: Emerging Options Across the Lifespan
- and more...
Express your interest and register for one of these events today.
Our findings demonstrate that Kiss1r is necessary to the effect of kisspeptin on prolactin secretion, although TIDA neurons lack Kiss1r and are electrically unresponsive to kisspeptin.
Evidence supports a role for fibrocytes in the pathogenesis of TAO. Recognition of their presence in the orbit now allows development of therapies specifically targeting these cells that ultimately could allow the restoration of immune tolerance within the orbit and perhaps systemically.
This review offers some guiding principles for the application of free testosterone measurements in the diagnosis and treatment of patients with androgen disorders.
We identified 33 candidate driver genes of sporadic PC, in addition to previously known driver genes CDC73 and MEN1.